Tag: director

Maui Land & Pineapple Company, Inc. Appoints a Chief Investment Officer

KAPALUA, Hawai‘i, June 09, 2026 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today announced the appointment of Ryan Panopio as the Company’s Chief Investment Officer effective June 3, 2026.

TerrAscend Announces Results of Annual General Meeting

TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced the results of its annual meeting of shareholders held on June 9, 2026 (the “Meeting”). Common shareholders at the Meeting affirmatively approved the following resolutions:

For its first anniversary, Ax.c announces $1.5M and shifts into international mode

The City of Montréal renews its financial support, and a partnership with DMZ will strengthen opportunities for startups internationally. Montreal, June 9, 2026 /CNW/...

KENCO STEPS-UP AS ‘OFFICIAL SPONSOR OF STAYING AWAKE’ AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT

Published match timings show Central European fans face 71 late-night kick-offs (68.3% of the tournament).UK fans face 60 late-night matches (57.7%), while Eastern European...

Director/PDMR Shareholding

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to lasmecabtagene timgedleucel (lasme-cel), its CD22-targeting allogeneic CAR-T cell therapy product candidate, for the treatment of patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL).

Éduc’alcool welcomes Yvan Gendron as Chair of its Board of Directors

Topic: Binance Commits $250,000 to Support Frontline Ebola Response in Uganda and DRC

CORRECTION — Mysti’s Adult and Family Services Begins Statewide Rental Assistance Program Under Washington’s Health-Related Social Needs Initiative

Maui Land & Pineapple Company, Inc. Appoints a Chief Investment Officer

TerrAscend Announces Results of Annual General Meeting

For its first anniversary, Ax.c announces $1.5M and shifts into international mode

KENCO STEPS-UP AS ‘OFFICIAL SPONSOR OF STAYING AWAKE’ AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT

Director/PDMR Shareholding

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

First Mining Announces Voting Results from 2026 AGM

First Mining Announces Voting Results from 2026 AGM

Folger Theatre Announces Final Play of Upcoming All-Shakespeare Season: The Comedy of Errors

TWAICE Partners with BayWa r.e. to Provide BESS Analytics for 282 MWh Storage Site in Germany

Albert Einstein College of Medicine Launches BIO-VITAL to Accelerate Gerotherapeutics

Pine County History Museum is Achieving Energy Independence with All Energy Solar

CFG Bank Launches CFG Mortgage Partners; Appoints Industry Veteran Dan Sacks to Lead New Initiative

GENESIS AND GENESIS INSPIRATION FOUNDATION PROMOTE STEAM LEARNING IN CHICAGO

Explore

Press Releases

News & Opinion

Living

Others

Follow us